LabCompass

Sarah Taleb

Medicine · The Ohio State University

Early career · publishing since 2018

Publications

27

Citations

194

Est. group size

~4

Recurring co-author estimate

Active years

8

Publishing since 2018

Research summary
AI-generated

Sarah Taleb's work focuses on medical research related to COVID-19 outcomes, epigenetics (DNA methylation and biological aging markers), lung disease mechanisms, and cardiovascular/kidney-related drug safety, such as hyperkalemia risk in hypertension treatment. The research combines clinical/register-based studies with molecular biology approaches to understand disease severity and treatment risks.

COVID-19 and acute respiratory distress syndromeDNA methylation and epigenetic agingLung fibrosis and myofibroblast biologyHypertension treatment and kidney-related side effectsTraditional and alternative medicine approaches

Publication output was minimal before 2020, peaked sharply in 2022, and has continued at a moderate, somewhat variable pace through 2024.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 4.2/year recently
172018: 1 publication18192020: 3 publications202021: 2 publications212022: 11 publications11222023: 4 publications232024: 5 publications242025: 1 publication2526
Recent publications
Publishes in
  • Figshare×6
  • Journal of Cellular Physiology×2
  • The American Journal of Chinese Medicine×1
  • Translational research×1
  • Journal of Translational Medicine×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile